
Rio Grande Neurosciences
Total Raised
$8.93MInvestors Count
1Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Rio Grande Neurosciences has raised $8.93M over 6 rounds.
Rio Grande Neurosciences's latest funding round was a Acquired for on December 27, 2017.
Rio Grande Neurosciences's latest post-money valuation is from December 2017.
Sign up for a free demo to see Rio Grande Neurosciences's valuations in December 2017 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
12/27/2017 | Acquired | 1 | ||||
2/10/2016 | Unattributed - III | |||||
1/6/2016 | Unattributed - II | |||||
10/26/2015 | Debt | |||||
5/5/2015 | Unattributed |
Date | 12/27/2017 | 2/10/2016 | 1/6/2016 | 10/26/2015 | 5/5/2015 |
|---|---|---|---|---|---|
Round | Acquired | Unattributed - III | Unattributed - II | Debt | Unattributed |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Rio Grande Neurosciences Deal Terms
1 Deal Term
Rio Grande Neurosciences's deal structure is available for 1 funding round, including their Acquired from December 27, 2017.
Round | Acquired |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired |
Rio Grande Neurosciences Investors
1 Investors
Rio Grande Neurosciences has 1 investors. Endonovo Therapeutics invested in Rio Grande Neurosciences's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
12/27/2017 | 12/27/2017 | 1 Acquired | Corporation | California |
First funding | 12/27/2017 |
|---|---|
Last Funding | 12/27/2017 |
Investor | |
Rounds | 1 Acquired |
Board Seats | |
Type | Corporation |
Location | California |
Rio Grande Neurosciences Acquisitions
1 Acquisition
Rio Grande Neurosciences acquired 1 company. Their latest acquisition was Cervel Neurotech - Multi-Coil TMS Technology on October 20, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/20/2015 | Acquired Unit | 1 |
Date | 10/20/2015 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired Unit |
Sources | 1 |
Loading...

